TowardPi Medical Enters Spanish Market with High-End OCT Devices Through Strategic Partnership with OCULUS Iberia

Aug 28, 2024 09:34 CST Updated 09:34

TowardPi

High-end Ophthalmic Medical Device Developer

OCULUS Iberia

Ophthalmic Equipment Provider

Source: Eye Future; Editor: Seven Kite

Reprint requirements: Can be reprinted 24 hours after the first publication, source must be credited.

Recently,TowardPi (Beijing) Medical Technology Co., Ltd.(TowardPi Medical) Officially Announces Partnership withOCULUS Iberia Establish a strategic partnership.This strategic cooperation meeting willDomestically Produced and Self-Developed10-40万 Speed Full-range Swept-source OCT/OCTA TechnologyOfficially Launched in the Spanish Market。

TowardPi's Full-Spectrum OCT Product Franchise,Fills the gap in high-end OCT products for OCULUS Iberia, will become an important piece of the puzzle for OCULUS in the Spanish ophthalmic product market.

# Product Introduction

Ophthalmic OCT products are the earliest and most advantageous high-end product line of TowardPi.OCT, fully known as Optical Coherence Tomography, is the most advanced imaging examination equipment in ophthalmology. Almost all fundus diseases and most anterior segment disease examinations require OCT images for diagnosis, thus it is referred to asThe "Gold Standard" for Ophthalmic Diagnosis。

TowardPi's OCT products include"Bei Ming·Kun" and "Yao Guang·Xing" can provide 400,000 and 100,000 full-field scanning capabilities respectively.。In terms of technical parameters such as scanning speed, imaging depth, and imaging range, it comprehensively outperforms imported flagship products, with its leading ultra-wide-angle blood flow imaging technology.Directly promoted the inclusion of the "ultra-widefield OCTA" clinical imaging function in the "2022 Chinese Diabetic Retinopathy Diagnosis Guidelines"This is also the first time that a clinical diagnosis guideline in the ophthalmology field has been driven by China's indigenous technology.

TowardPi's "Beihming" OCT product, released in 2020, is the world's first commercially available swept-source OCT product with a scanning speed of 400,000 A-scans per second.TowardPi's ophthalmic OCT products achieve "double first" in market share and average winning bid price, is a rare case in the industry where the quantity and price of domestically produced products are both higher than those of imported brands., indicating that its product strength is significantly ahead.

In 2023,TowardPi's Ophthalmic OCT Products Enter Public Hospitals in ChinaMarket share has reached 27%, ranking first in the Chinese market.`, and is also the first to achieve`Comprehensive Layout of High-End Ophthalmic Medical Devices "Full Product Line"Chinese enterprises.

As of 2023, the total market share of domestically produced ophthalmic OCT products in China has exceeded 50%. Chinese brands represented by TowardPi have performed remarkably in the mid-to-high-end market, surpassing imported products in overall product strength. In the next three years,Driven by numerous domestic brands, ophthalmic OCT products are expected to achieve a higher degree of localization in China.。

# Ophthalmology OCT Market Size

According to data from the Lasker Foundation in the United States, OCT imaging technology is used more than 30 million times annually in ophthalmic surgeries, approximately once per second. Going forward, it will be...Globally, approximately 40 million OCT eye examinations are performed each year.。Global Ophthalmology OCT Market SizeIt is expected to grow at a compound annual growth rate of 15.41% from 2022 to 2030., it is estimated thatReach 1.9703 billion US dollars in 2029.

▲Global Ophthalmology OCT Market Sales Size and Growth Trend Forecast

Data Sourcegrand view research

According to the estimation in the White Paper on Innovation in China's Cardiovascular Medical Device Industry,By 2025, China's OCT Has 25 Times Growth Space。According to statistics, in 2022, the market size of ophthalmic OCT in China was 800 million yuan;In 2023, the market size of ophthalmic OCT in China was 1.1 billion yuan, with a compound annual growth rate exceeding 37%.，It is expected to grow to 2.2 billion yuan by 2028.，OCT with the OCT-A module will be the mainstream of future market upgrades.

▲Market Size and Growth Trend Forecast of China's Ophthalmic OCT (Unit: Billion Yuan)

Data sources from national and provincial procurement websites

# Company Introduction

TowardPi was founded in 2017,Core technology derived from the transformation of scientific and technological achievements of Tsinghua University, and incubated by the Tsinghua Industrial Research Institute.Incubation. The core technology team of TowardPi Medical consists of dozens of teachers and students from various majors such as electronics, biomedical, and precision instruments at Tsinghua University. Relying on the Tsinghua technology platform, they have developed a series of world-leading high-end medical devices.

The company currently has a scale of more than 300 employees.Among them, the R&D team consists of more than a hundred people., with an annual R&D investment of nearly 100 million RMBTowardPi has R&D centers in Beijing and Shanghai, as well as manufacturing bases in Beijing, Suzhou, and Tianjin.

The company's product line covers ophthalmic OCT, surgical microscopes, ultra-widefield fundus cameras, optical biometers, etc., with products sold in dozens of countries worldwide.，Sales and installations have been achieved in many countries such as France, Italy, Switzerland, the Netherlands, and Greece. Overseas revenue has started to grow, and the global layout is gradually improving. In addition, the company also...TowardPi has femtosecond laser and phacoemulsification vitrectomy product lines under development.

# OCULUS Iberia

OCULUS Iberia was founded in 2011 and is headquartered in Madrid, Spain.As a subsidiary of OCULUS Optikgeräte GmbHOCULUS Iberia also offers a comprehensive product portfolio, including both self-manufactured and distributed products, with OCT being part of its offerings. Representatives of OCULUS Iberia in regions such as Andalusia, Catalonia, Galicia, Levante, and Madrid ensure timely and personalized responses to customer inquiries across Spain, reflecting a strong commitment to customer support.

OCULUS Optikgeräte GmbH, founded in 1895, is headquartered in Wetzlar, Germany. As a family business, it has grown into a trusted global partner for ophthalmic healthcare professionals. Its series of products, such as the Pentacam, a three-dimensional anterior segment analyzer, enjoy a high reputation worldwide. OCULUS is now managed by the third and fourth generations.Continuously innovate in the design and manufacture of high-quality ophthalmic equipment.。OCULUS has 12 subsidiaries in Europe, Asia, and the Americas, with products marketed in over 80 countries and regions.。